Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 54

Sort by

Sort Order Select

Journal Articles

Dual Epigenetic Agents Plus Rituximab-Gemcitabine-Oxaliplatin As a Salvage Treatment in Relapsed/Refractory Diffuse Large B Cell Lymphoma Patients

Changju Qu, PhD, Nana Ping, MD, PhD, Danqing Kong, MD, Fan Xia, MD, Depei Wu, MD PhD, Zhengming Jin, MD

Blood (2019) 134 (Supplement_1): 5338.

https://doi.org/10.1182/blood-2019-128111

Published: 2019

Journal Articles

Functional Analysis of HDAC11 in Plasma Cell Development and Multiple Myeloma Survival

AGM Mostofa, PhD, Allison Distler, Mark B. Meads, PhD, Eva Sahakian, PhD, John J. Powers, BS, Tuan Nguyen, Melissa Alsina, MD, Taiga Nishihori, MD, Rachid Baz, MD, Javier Pinilla Ibarz, MD, Eduardo Sotomayor, MD, Kenneth H. Shain, MD PhD, Jason B. Brayer, PhD MD

Blood (2018) 132 (Supplement 1): 3223.

https://doi.org/10.1182/blood-2018-99-119119

Published: 2018

Journal Articles

Histone Deacetylase Inhibitors Abolish HBZ Protein Expression and Induce Cell Death in HTLV-1 Related Adult T-Cell Leukemia-Lymphoma

Ngoc L Toomey, BS, Juan Carlos Ramos, MD BS

Blood (2017) 130 (Supplement 1): 4012.

https://doi.org/10.1182/blood.V130.Suppl_1.4012.4012

Published: 2017

Journal Articles

HDAC11 Is a Candidate Therapeutic Target in Multiple Myeloma

Jason B. Brayer, PhDMD, Allison Distler, Mark B. Meads, PhD, Eva Sahakian, PhD, John J. Powers, BS, Tuan Nguyen, Melissa Alsina, MD, Taiga Nishihori, MD, Rachid Baz, MD, Javier Pinilla-Ibarz, MD PhD, Eduardo Martin Sotomayor, MD, Ken H Shain, MD PhD

Blood (2017) 130 (Supplement 1): 1800.

https://doi.org/10.1182/blood.V130.Suppl_1.1800.1800

Published: 2017

Journal Articles

Infrared Thermal Imaging Maybe an Available Tool to Detect Arthrorrhagia in Patients with Hemophilia

Xuan Zhou, PhD, Xueyan Sun, Zhuqin Liu, Jinmu Zhuang, Jieyu Ye, Qifa Liu, MD, Jing Sun, MD

Blood (2017) 130 (Supplement 1): 4887.

https://doi.org/10.1182/blood.V130.Suppl_1.4887.4887

Published: 2017

Journal Articles

The TLR Adaptor Protein MyD88 Mediates Cell Sensitivity to HDAC Inhibitors through a Cytokine-Dependent Mechanism

Semira Sheikh, MDBSc,FRCPath, Maria New, PhD, Mina Bekheet, Heidi Olzscha, PhD, Nicholas B La Thangue, PhD FRSE FMedSci

Blood (2016) 128 (22): 1766.

https://doi.org/10.1182/blood.V128.22.1766.1766

Published: 2016

Journal Articles

Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma

Blood (2016) 128 (2): 185–194.

https://doi.org/10.1182/blood-2016-02-699520

Published: 2016

Includes: Supplemental data

Journal Articles

Childhood Hyperdiploid Acute Lymphoblastic Leukemia

Marketa Zaliova, Martina Vaskova, Lenka Hovorkova, Ondrej Hrusak, Jan Stary, Jan Zuna

Blood (2015) 126 (23): 4990.

https://doi.org/10.1182/blood.V126.23.4990.4990

Published: 2015

Journal Articles

Identification and Mechanistic Characterization of CMPD1 As a Selective Sensitizer of Histone Deacetylase Inhibitors in Myeloid Malignancies

James M Bogenberger, PhD, Nanna Hansen, M.S., Devora Delman, B.S., Ruben A. Mesa, Raoul Tibes, MD

Blood (2015) 126 (23): 3689.

https://doi.org/10.1182/blood.V126.23.3689.3689

Published: 2015

Journal Articles

The Combination of Belinostat with Zidovudine for Treatment of HTLV-I Related Adult T-Cell Leukemia-Lymphoma

Ngoc Toomey, Juan Carlos Ramos, MD

Blood (2015) 126 (23): 1562.

https://doi.org/10.1182/blood.V126.23.1562.1562

Published: 2015

Journal Articles

A Randomized, Phase II Study with Biomarker Analysis of Panobinostat with or without Rituximab in Relapsed Diffuse Large B Cell Lymphoma

Sarit Assouline, Michael Crump, MD, Torsten Holm Nielsen, Miguel Alcaide, B. Sc., Ph. D., David Macdonald, MD FRCPC, Axel Tosikyan, Tina Haliotis, Celia Greenwood, Kathleen Klein Oros, Ryan Morin, PhD, Nathalie Johnson, MD PhD, Koren Kathleen Mann, PhD

Blood (2015) 126 (23): 2719.

https://doi.org/10.1182/blood.V126.23.2719.2719

Published: 2015

Journal Articles

A Novel Role for Histone Deacetylase 11 (HDAC11) in B Cell Lymphopoiesis and Plasma Cell Survival in Multiple Myeloma

Jason B. Brayer, MDPhD, Eva Sahakian, PhD, John Powers, M.S., Mark B Meads, PhD, Susan Deng, Allison Distler, Melissa Alsina, MD, Taiga Nishihori, MD, Rachid Baz, MD, Alejandro Villagra, PhD, Javier Pinilla-Ibarz, MD PhD, Eduardo M. Sotomayor, MD, Kenneth H. Shain, MD PhD

Blood (2014) 124 (21): 4715.

https://doi.org/10.1182/blood.V124.21.4715.4715

Published: 2014

Journal Articles

Cost-Effectiveness Analysis (CEA) of Sequential Treatment with Tyrosine Kinase Inhibitors (TKIs) for Chronic Myelogenous Leukemia (CML)

John Whalen, BS, Ipek Stillman, MS, Apoorva Ambavane, MPH, Eugene Felber, PhD MSPH, Dinara Makenbaeva, MD MBA, Bjorn Bolinder, MBA

Blood (2014) 124 (21): 2607.

https://doi.org/10.1182/blood.V124.21.2607.2607

Published: 2014

Journal Articles

Transcription Regulation Targeting in Peripheral T Cell Lymphomas Induces Apoptosis and Sensitization to BCL2 Inhibitors

Pannee Praditsuktavorn, MD, Benet Pera, PhD, Nicholas Kwiatkowski, PhD, ShaoNing Yang, MS, Tinghu Zhang, PhD, Nathanael Gray, PhD, Leandro Cerchietti, MD

Blood (2014) 124 (21): 810.

https://doi.org/10.1182/blood.V124.21.810.810

Published: 2014

Journal Articles

AMC075: The Combination of Vorinostat with Chemotherapy and Rituximab Is Tolerable and Feasible in HIV-Related B-Cell Non-Hodgkin’s Lymphoma with High-Risk Features

Juan Carlos Ramos, MD, Joseph Sparano, MD, Page Moore, Jeannette Y. Lee, Michelle A Rudek, Richard F. Ambinder, Ethel Cesarman, MD PhD, Ariela Noy, MD, Ronald T. Mitsuyasu, MD

Blood (2014) 124 (21): 4473.

https://doi.org/10.1182/blood.V124.21.4473.4473

Published: 2014

Journal Articles

MK2a Substrate-Selective p38 Inhibitor CMPD1 Selectively Synergizes with HDAC Inhibitors in CD34 + Cells from Myeloid Malignancies

James M Bogenberger, PhD, Nanna Hansen, M.S., Devora Delman, B.S., Ruben A. Mesa, MD, Raoul Tibes, MD PhD

Blood (2014) 124 (21): 2239.

https://doi.org/10.1182/blood.V124.21.2239.2239

Published: 2014

Journal Articles

Acute Myeloid Leukemia: Challenges and Real World Data from India

Chepsy C Philip, MD, Biju Geoge, MD, Abhijeet Ganapule, MD, Kavitha M Lakshmi, MSc, Fouzia N Abubacker, MD, Aby Abraham, MD, Auro Viswabandya, MD, Vivi M Srivastava, MD, Alok Srivastava, MD, Poonkuzhali Balasubramanian, PhD, Vikram Mathews, MD

Blood (2014) 124 (21): 3685.

https://doi.org/10.1182/blood.V124.21.3685.3685

Published: 2014

Journal Articles

Association Of Health Care Expenditure With Results Of Allogeneic HSCT For Adults With ALL: An Analysis From Acute Leukemia Working Party Of The EBMT

Sebastian Giebel, MD, Myriam Labopin, MD, Adalberto Ibatici, MD, Paul Browne, MD, Tomasz Czerw, Gérard Socié, MD, PhD, Ali Unal, MD, Slawomira Kyrcz-Krzemien, MD, Andrea Bacigalupo, MD, Hakan Goker, MD, Michael N Potter, MBBS, PhD, Grant McQuaker, MD, Dietrich Beelen, MD, Noel Milpied, MD, PhD, Antonio Campos, MD, Charles Craddock, MD DPhil, Mohamad Mohty, MD, PhD

Blood (2013) 122 (21): 2150.

https://doi.org/10.1182/blood.V122.21.2150.2150

Published: 2013

Journal Articles

Quantitation of Leukemic Stem Cell Populations Predicts Clinical Outcome in Acute Myeloid Leukaemia

Charles F. Craddock, MD PhD, Nicolas Goardon, PhD, Lynn Quek, MD, Sylvie Freeman, MD, PhD, Shamyla Siddique, Manoj Raghavan, Anna Schuh, PhD, David Grimwade, PhD, Robert K Hills, MA, MSc, DPhil, Cassandra Brookes, PhD, Michael Griffiths, PhD, James D. Cavenagh, MD, Ravindra Majeti, MD, PhD, Irving L. Weissman, MD, Alan K Burnett, MD, Paresh Vyas

Blood (2011) 118 (21): 638.

https://doi.org/10.1182/blood.V118.21.638.638

Published: 2011

Journal Articles

Epigenetic Modulation of STAT3 by Histone Deacetylase 6 (HDAC6) Regulates IL-10 Gene Expression and Immune Tolerance Mediated by Antigen-Presenting Cells (APCs)

Fengdong Cheng, Zi Wang, Hongwei Wang, Karrune V. Woan, Eva Sahakian, Ph.D, Jennifer Rock Klotz, Liqing Wang, Rongxiang Han, Oscar Merino, Susan Deng, Lianet Vazquez, Ajaypal S. Gill, Danay Marante, John Powers, B.S., Wayne W. Hancock, Javier Pinilla, Edward Seto, Eduardo M. Sotomayor, Alejandro Villagra

Blood (2011) 118 (21): 519.

https://doi.org/10.1182/blood.V118.21.519.519

Published: 2011

NARROW

Dual Epigenetic Agents Plus Rituximab-Gemcitabine-Oxaliplatin As a Salvage Treatment in Relapsed/Refractory Diffuse Large B Cell Lymphoma Patients

Functional Analysis of HDAC11 in Plasma Cell Development and Multiple Myeloma Survival

Histone Deacetylase Inhibitors Abolish HBZ Protein Expression and Induce Cell Death in HTLV-1 Related Adult T-Cell Leukemia-Lymphoma

HDAC11 Is a Candidate Therapeutic Target in Multiple Myeloma

Infrared Thermal Imaging Maybe an Available Tool to Detect Arthrorrhagia in Patients with Hemophilia

The TLR Adaptor Protein MyD88 Mediates Cell Sensitivity to HDAC Inhibitors through a Cytokine-Dependent Mechanism

Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma

Childhood Hyperdiploid Acute Lymphoblastic Leukemia

Identification and Mechanistic Characterization of CMPD1 As a Selective Sensitizer of Histone Deacetylase Inhibitors in Myeloid Malignancies

The Combination of Belinostat with Zidovudine for Treatment of HTLV-I Related Adult T-Cell Leukemia-Lymphoma

A Randomized, Phase II Study with Biomarker Analysis of Panobinostat with or without Rituximab in Relapsed Diffuse Large B Cell Lymphoma

A Novel Role for Histone Deacetylase 11 (HDAC11) in B Cell Lymphopoiesis and Plasma Cell Survival in Multiple Myeloma

Cost-Effectiveness Analysis (CEA) of Sequential Treatment with Tyrosine Kinase Inhibitors (TKIs) for Chronic Myelogenous Leukemia (CML)

Transcription Regulation Targeting in Peripheral T Cell Lymphomas Induces Apoptosis and Sensitization to BCL2 Inhibitors

AMC075: The Combination of Vorinostat with Chemotherapy and Rituximab Is Tolerable and Feasible in HIV-Related B-Cell Non-Hodgkin’s Lymphoma with High-Risk Features

MK2a Substrate-Selective p38 Inhibitor CMPD1 Selectively Synergizes with HDAC Inhibitors in CD34 + Cells from Myeloid Malignancies

Acute Myeloid Leukemia: Challenges and Real World Data from India

Association Of Health Care Expenditure With Results Of Allogeneic HSCT For Adults With ALL: An Analysis From Acute Leukemia Working Party Of The EBMT

Quantitation of Leukemic Stem Cell Populations Predicts Clinical Outcome in Acute Myeloid Leukaemia

Epigenetic Modulation of STAT3 by Histone Deacetylase 6 (HDAC6) Regulates IL-10 Gene Expression and Immune Tolerance Mediated by Antigen-Presenting Cells (APCs)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only